Healio12d
Adding anifrolumab superior to standard therapy alone, maintains remission in lupus
Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...
pharmaphorum3d
AZ fleshes out positive trial of revitalised lupus drug anifrolumab
AZ said in the summer that anifrolumab had met its objectives in the phase 3 TULIP-2 trial, around a year after it flunked an earlier study (TULIP-1) which had caused many to dismiss any prospect ...
pharmaphorum3y
FDA approves AZ's anifrolumab, ending 10-year lupus drug drought
Anifrolumab was all-but written off in 2018 after failing the phase 3 TULIP-1 trial, but bounced back ... despite earlier reservations that its mixed clinical results might stand in the way ...